Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke ? A clinical practice guideline
ContributorsKuijpers, Ton; Spencer, Frederick A; Siemieniuk, Reed A C; Vandvik, Per O; Otto, Catherine M; Lytvyn, Lyubov; Mir, Hassan
; Jin, Albert Y; Manja, Veena; Karthikeyan, Ganesan
; Hoendermis, Elke; Martin, Janet
; Carballo, Juan Sebastian
; O'Donnell, Martin
; Vartdal, Trond; Baxter, Christine; Patrick-Lake, Bray; Scott, Joanie; Agoritsas, Thomas
; Guyatt, Gordon
Published inBMJ. British medical journal, vol. 362, k2515
Publication date2018-07-25
First online date2018-07-25
Keywords
- Anticoagulants / therapeutic use
- Clinical Decision-Making / methods
- Foramen Ovale, Patent / surgery
- Humans
- Platelet Aggregation Inhibitors / therapeutic use
- Stroke / therapy
- Systematic Reviews as Topic
Affiliation entities
Citation (ISO format)
KUIJPERS, Ton et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke ? A clinical practice guideline. In: BMJ. British medical journal, 2018, vol. 362, p. k2515. doi: 10.1136/bmj.k2515
Main files (1)
Article (Published version)
Identifiers
- PID : unige:185559
- DOI : 10.1136/bmj.k2515
- PMID : 30045912
- PMCID : PMC6058599
Additional URL for this publicationhttps://www.bmj.com/lookup/doi/10.1136/bmj.k2515
Journal ISSN0959-8138
